DENZA Partners with DEVIALET on Car Audio System
On 22nd March 2023, the DENZA x DEVIALET Cooperation Kick-off Evening was held at the Bay Opera of Shenzhen. DENZA and DEVIALET jointly unveiled the DENZA N7, the world's first mass-produced model coming with the DEVIALET car audio system. This cooperation witnesses DENZA become the first brand to apply DEVIALET’s audio system and serves as a paradigm of international cooperation in the global automotive industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230323005522/en/
DENZA x DEVIALET Cooperation Kick-off Evening (Photo: Business Wire)
Zhao Changjiang, General Manager of DENZA, said: “High-quality music brings users enjoyment of life, and intelligent music cockpit is the standard element for the new luxury.”
Franck Lebouchard, CEO of DEVIALET, commented, “This is a collaboration between two market leaders with a mission to redefine sound experiences in mobility. Our partnership with DENZA marks a partnership concluded with a future leading player in the automotive market.”
Making the journey sound better, DENZA N7 comes with a new acoustic system that offers Hi-Fi sounds with cutting-edge technology and creates an intelligent music cockpit offering an immersive and pleasant sound experience. The tailor-made speaker in DENZA N7 can create an expansive yet precise sound field while preserving Hi-Fi precision. The SAM® (Speaker Active Matching) technology is employed to produce ultra-low frequencies down to 20Hz, creating a more powerful bass performance. The DEVIALET SPACE technology is used to deliver stereo sound effects and create an immersive ambiance. The SDVC (Speed Dependent Volume Control) technology unique to DEVIALET provides automatic volume adjustment depending on the speed of the vehicle.
DENZA N7 is where auto-design aesthetics meets with the art of acoustics. It features a look that inherits the DENZA family’s new design language, π-Motion. The golden ratio of 0.618 and the design of the long wheelbase combined with short front and rear suspensions render an elegant yet sporty body. The “Meteor Arrow” symbol running through the body presents a sharp-cut vibrant mark that is easy to identify. The front of N7 looks like a “bullet” pointing forward, creating a feeling of high speed. The waistlines are the perfect embodiment of the π-Motion design language as well. Fluent and graceful, the curved surface is seemingly poised to rein the wind. The one-piece through taillight strip extends to both sides, making it look as wide as a shooting brake. Zhao Changjiang said: “As a unique all-electric shooting brake, DENZA N7 brings perceived value that outstrips oil-fueled luxury SUVs and takes the exterior design of electric SUVs to the next level.”
Amid a new wave of internationalization, DENZA will align with more premium brands across multiple sectors, enrich the aesthetic meaning of luxury life, and bring an intelligent, accessible, and comfortable mobility experience to global users.
HD Photos: https://we.tl/t-nxUJMK6LWT
About DENZA
In 2010, Mercedes-Benz, as the "inventor of automobile", and BYD Auto, as the "leader of new energy vehicles", established DENZA, China's first joint venture brand of new energy vehicles with a high-end brand position to realize their common vision of the future of electric mobility by complementing each other's strengths. DENZA combines BYD's world-leading power batteries, electric motors, electronic control systems with Mercedes-Benz's intelligent manufacturing capability, vehicle tuning, and quality management systems.
About DEVIALET
DEVIALET is a French acoustical engineering company operating at the intersection of luxury and cutting-edge technology. DEVIALET’s mission is to elevate sound to its rightful place in people's lives by delivering uniquely meaningful audio experiences through iconic products.
About BYD
BYD is a multinational high-tech company devoted to leveraging technological innovations for a better life. Founded in 1995 as a rechargeable battery maker, BYD now boasts a diverse business scope covering automobiles, rail transit, new energy, and electronics, with over 30 industrial parks in China, the United States, Canada, Japan, Brazil, Hungary, and India. From energy generation and storage to its applications, BYD is dedicated to providing zero-emission energy solutions that reduce global reliance on fossil fuels. Its new energy vehicle footprint now covers 6 continents, over 70 countries and regions, and more than 400 cities. Listed in both Hong Kong and Shenzhen Stock Exchanges, the company is known to be a Fortune Global 500 enterprise that furnishes innovations in pursuit of a greener world.
About BYD Auto
Founded in 2003, BYD Auto is the automotive subsidiary of BYD, a multinational high-tech company devoted to leveraging technological innovations for a better life. Aiming to accelerate the green transition of the global transportation sector, BYD Auto focuses on developing pure electric and plug-in hybrid vehicles. The company has mastered the core technologies of the entire industrial chain of new energy vehicles, such as batteries, electric motors, electronic controllers, and automotive-grade semiconductors. It has witnessed in recent years significant technological advancements, including the Blade Battery, the DM-i and DM-p hybrid technology, the e-Platform 3.0, and the CTB technology. The company is the world’s first carmaker to stop the production of fossil-fueled vehicles on EV shift and has remained top of new energy passenger vehicle sales in China for 9 years in a row.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230323005522/en/
Contact information
Asia-Pacific: Mia Gu, pr@byd.com tel: +86-755-8988-8888-69666
Europe: Penny Peng, PressEU@byd.com tel: +31-102070888
North America: Frank Girardot, frank.girardot@byd.com tel: +1 213 245 6503
Latin America: José Miranda, jose.miranda@byd.com tel: +56 9 96443906
Brazil: Adalberto Maluf, adalberto.maluf@byd.com tel: +19 3514 2554
Middle East and Africa: Nikki Li, tel: +86-18938862670
About Business Wire
Business WireSubscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Climate Impact X Launches CIX Exchange to Level up Carbon Market Transparency, Certainty and Liquidity8.6.2023 02:00:00 CEST | Press release
Climate Impact X (CIX), a global marketplace, auctions house and exchange for trusted carbon credits, has successfully launched its spot trading platform, CIX Exchange, completing the company’s core solutions suite with three operational venues. Powered by Nasdaq's trading technology, CIX Exchange offers carbon market professionals a customised experience built on international best practices for platform stability, performance and governance. Users can efficiently discover market-driven prices, compare individual projects and trade standard contracts. To address industry calls for greater transparency and price certainty, CIX has introduced the first daily on-exchange liquidity window in the voluntary carbon market with firm bids and offers. This dedicated 30-minute pricing session pools all-day liquidity from Asia, Europe and Middle East to help sharpen benchmark prices and improve order depth for spot nature-based credits. By close of trading on 7 June 2023, bids and offers had conv
RevBio is Awarded a $2 Million Grant to Advance the Development of its Novel Dental Adhesive Bone Scaffold Product7.6.2023 23:12:00 CEST | Press release
RevBio, Inc., announced that it has been awarded a $2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health (NIH). This funding (1R44DE032564-01) will allow the company to complete the pre-clinical research necessary to advance this product into the clinical stage of development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230607005794/en/ The current standard of care options for rebuilding deficient jawbone includes a variety of materials that require membranes and time consuming fixation devices. These products do not predictably maintain ridge volume which requires surgeons to undergo re-grafting in over 30% of clinical cases. TETRANITE eliminates the use of membranes and other fixation devices, when compared to the standard of care. Furthermore, TETRANITE resorbs fully while maintaining predict
IFF Names New President of Nourish and Introduces Leadership Structure Aligned to New Operating Model7.6.2023 22:18:00 CEST | Press release
IFF (NYSE: IFF) today announced that Yuvraj Arora, currently President, U.S. Categories for Kellogg North America, will join IFF as President, Nourish, effective June 19, 2023. Arora brings more than 25 years of multinational CPG experience to IFF’s Executive Leadership Team, mostly recently leading Kellogg’s $7 billion U.S. portfolio through a period of strong growth and portfolio transformation. IFF today also announced the leadership structure to support the transition to a new operating model as part of the company’s transformation strategy. The shift from its current divisional structure to three core end markets—Food and Beverage, Home and Personal Care, and Health—will provide greater customer intimacy and enhance cross-functional collaboration, allowing for enhanced execution, speed and streamlined delivery. IFF expects its new operating model to be in effect by the beginning of 2024. As President, Nourish, Arora, will lead IFF’s Food and Beverage categories when the operating
Vizgen Issues Open Letter to Customers and Researchers on 10x Genomics June 1, 2023 Lawsuit Announcement in Europe7.6.2023 21:00:00 CEST | Press release
Vizgen, Inc. (“Vizgen” or the “Company”), a life science leader dedicated to improving human health by visualizing single-cell spatial genomics information, today issued the below open letter to customers and researchers in response to 10x Genomics, Inc. (“10x”) filing a lawsuit on June 1, 2023 with the Unified Patent Court (“UPC”) in Europe. *** June 7, 2023 Dear Customers, Researchers and Friends of Vizgen: We are disappointed – though not surprised – that 10x has filed another lawsuit that attempts to undermine innovation, eliminate competition and intimidate both customers and industry peers. Although 10x’s UPC complaint is not yet available to us, we will keep you updated as we learn more. In the meantime, rest assured that we will vigorously defend our shared interests in all proceedings with the UPC, much like we have in the ongoing litigation in the U.S. District Court for the District of Delaware. In the Delaware case, we have gone on the offensive to assert our own countercla
Brenus Pharma announces its international Scientific Committee7.6.2023 18:00:00 CEST | Press release
Following the American Society of Clinical Oncology’s Annual Meeting, where Brenus’ innovative approach and promising preclinical results were featured in the abstract section “Treatment to Follow” 1, the company highlighted its international scientific committee. This committee gathering renowned international experts in immuno-oncology, immunotherapies, and novel-treatments is supporting Brenus’ scientific developments of the STCplatform pipeline in solid tumors and its first candidate, STC-1010 targeting colorectal cancer. The committee combined a total of over 1,700 internationally peer-reviewed articles and prestigious awards in the field: Pr François GHIRINGHELLIMD, PhD. Pr of Oncology – Head of “Cancer and adaptative immune response” INSERM, CGFL2, Dijon. (FR) Head of the Board Pr Ahmad AWADAMD, PhD. Pr of Oncology – Head of Oncology medicine Dept. Jules Bordet Institute-HUB, Brussel. (BE) & Board member Oncodistinct clinical and translational research network, ESMO3 active memb
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom